Adolfo Cotter,MD

Brain-Mind Interface

Dr. Cotter practices Telemedicine in Primary Care. Conducts a competent, highly responsive Telemedicine practice since 2012, treating a variety of medical conditions from simple to very complex. Proficient with electronic medical records using a wide range of software packages and other forms of computing. Dr. Cotter also practiced Medicine doing Home Care, Urgent Care and Hospital Work.

Dr. Cotter has medical licenses in the states of Michigan, Indiana, and telehealth registration in the states of Minnesota and Florida. The links to the states medical boards are: Florida, http://www.flhealthsource.gov/telehealth/ Minnesota, https://mn.gov/boards/medical-practice/ Indiana, https://mylicense.in.gov/everification/ Michigan, https://www.michigan.gov/lara/0,4601,7-154-89334_72600_85566—,00.html

Dr. Adolfo Cotter founded Cognimetrix in 2007, motivated by a tremendous personal interest in the use of brain imaging data in the development of bionic based software to enhance creativity and intelligence.

Throughout his career, Dr. Cotter has performed brain imaging research in academic institutions such as Unversity of Toronto, University of Pennsylvania, and Emory University. He has also conducted brain imaging research for commercial companies such as at Cerebral Diagnostics.

Dr. Cotter has given lectures in Brain Imaging and attended numerous Brain Imaging meetings where he has presented his research projects. He has experience in brain imaging data acquisition and analysis for technologies such as PET, SPECT, MRI, fMRI and EEG. During his brain imaging analysis work, he has done biostatistics using a variety of software programs.

NY Times article

Last month, a major step forward was taken towards bringing the science of brain imaging into mainstream clinical practice. It appears imminent that the FDA will approve the use of PET  scans for amyloid plaques as a diagnostic test for Alzheimer’s disease.

In my opinion this is a great first step.

Next we should look at combining this test with an anatomical one, such as  MRI , that looks for and measures hippocampal volume. The anatomical test should increase the overall test accuracy.

Although the NY Times article states: “Plaques are part of the criteria for having Alzheimer’s” if a person with memory problems does not have plaques, that person does not have Alzheimer’s it has also been shown that amyloid plaques do not correlate with cognitive changes in Alzheimer’s disease. The ultimate test would be possible only after a more complete understanding of Alzheimer’s disease pathophysiology.

The NY Times article was published on the health section on January 20th 2011. http://www.nytimes.com/2011/01/21/health/21alzheimers.html

Adolfo Cotter, MD

Mar 09/2011

Adolfo Cotter, MD's avatar

Posted by:

Adolfo Cotter, MD

Leave a comment